These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28730674)

  • 1. Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
    Gkalpakiotis S; Arenberger P; Fridman M; Arenbergerova M
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28730674
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
    Gkini MA; Bewley AP
    Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience.
    Bardazzi F; Magnano M; Campanati A; Loconsole F; Carpentieri A; Potenza C; Bernardini N; Di Lernia V; Carrera C; Raone B; Patrizi A; Loi C
    Acta Derm Venereol; 2017 Aug; 97(8):989-990. PubMed ID: 28512671
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trial.
    Puig L; Lebwohl M; Bachelez H; Sobell J; Jacobson AA
    J Am Acad Dermatol; 2020 Feb; 82(2):352-359. PubMed ID: 31175909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.
    Langley RG; Lebwohl M; Krueger GG; Szapary PO; Wasfi Y; Chan D; Hsu MC; You Y; Poulin Y; Korman N; Prinz JC; Reich K;
    Br J Dermatol; 2015; 172(5):1371-83. PubMed ID: 25307931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
    Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
    Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ustekinumab in the treatment of palmoplantar pustular psoriasis - a case series of nine patients.
    Buder V; Herberger K; Jacobi A; Augustin M; Radtke MA
    J Dtsch Dermatol Ges; 2016 Nov; 14(11):1108-1113. PubMed ID: 27879067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
    Leonardi CL
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S74-7. PubMed ID: 27551698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and skin clearance recapture in clinical studies of brodalumab.
    Bagel J; Lebwohl M; Israel RJ; Jacobson A
    J Am Acad Dermatol; 2020 Feb; 82(2):344-351. PubMed ID: 31175910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rare Case of Amyopathic Juvenile Dermatomyositis Associated With Psoriasis Successfully Treated With Ustekinumab.
    Montoya CL; Gonzalez ML; Ospina FE; Tobón GJ
    J Clin Rheumatol; 2017 Mar; 23(2):129-130. PubMed ID: 28099216
    [No Abstract]   [Full Text] [Related]  

  • 11. Brodalumab versus ustekinumab in psoriasis.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):298. PubMed ID: 26627075
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab.
    Hesselvig JH; Egeberg A; Loft ND; Zachariae C; Kofoed K; Skov L
    Acta Derm Venereol; 2018 Mar; 98(3):335-339. PubMed ID: 29110019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ustekinumab in five psoriatic patients with hepatitis B virus infection.
    Piaserico S; Conti A; Coati I; Galdo G; Bernabucci V; Zanca A; Drabeni M; Masutti F; Musumeci ML; Alberti A; Russo FP
    G Ital Dermatol Venereol; 2019 Jun; 154(3):376-377. PubMed ID: 28712266
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of systemic therapies in the treatment of psoriasis with concomitant cirrhosis: a retrospective study.
    Blaszczak AM; Dunaway S; Ali Alikhan M; Kelly S; Levin D; Kaffenberger J
    Int J Dermatol; 2019 Nov; 58(11):e228-e229. PubMed ID: 31334835
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple Clustered Dermatofibromas Following Ustekinumab Treatment for
    Ruiz-Villaverde R; Díaz-Martinez MA; Sánchez-Cano D
    Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e375-e377. PubMed ID: 29062570
    [No Abstract]   [Full Text] [Related]  

  • 16. Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab.
    Kolios AGA; Biedermann L; Weber A; Navarini AA; Meier J; Cozzio A; French LE
    Br J Dermatol; 2018 Feb; 178(2):551-555. PubMed ID: 28477389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus.
    Chiricozzi A; Pimpinelli N; Ricceri F; Bagnoni G; Bartoli L; Bellini M; Brandini L; Caproni M; Castelli A; Fimiani M; Marsili F; Mazzatenta C; Niccoli MC; Panduri S; Pellegrino M; Sirna R; Volpi W; Romanelli M; Prignano F
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28940579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies.
    Watson N; Wu K; Farr P; Reynolds NJ; Hampton PJ
    Br J Dermatol; 2019 Jan; 180(1):195-196. PubMed ID: 30101563
    [No Abstract]   [Full Text] [Related]  

  • 19. Inverse psoriasis treated with ustekinumab.
    Campos MA; Varela P; Baptista A; Moreira AI
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27222277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequate response to ustekinumab in atopic dermatitis - a report of two patients.
    Samorano LP; Hanifin JM; Simpson EL; Leshem YA
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):522-3. PubMed ID: 25510643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.